Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

BACKGROUND: Patients with chronic idiopathic/spontaneous urticaria (CIU/CSU) report difficulty with sleep. METHODS: We examined the effect of omalizumab on sleep-related outcomes during 3–6 months omalizumab or placebo treatment and a 16-week follow-up period within three Phase III double-blind rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Gimenéz-Arnau, Ana M., Spector, Sheldon, Antonova, Evgeniya, Trzaskoma, Benjamin, Rosén, Karin, Omachi, Theodore A., Stull, Donald, Balp, Maria-Magdalena, Murphy, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989527/
https://www.ncbi.nlm.nih.gov/pubmed/27540466
http://dx.doi.org/10.1186/s13601-016-0120-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4989527/
https://www.ncbi.nlm.nih.gov/pubmed/27540466
http://dx.doi.org/10.1186/s13601-016-0120-0

Ejemplares similares